发明公开
- 专利标题： OXAZINE DERIVATIVE
- 专利标题（中）： OXAZINDERIVAT
-
申请号： EP10836054.6申请日： 2010-12-10
-
公开(公告)号： EP2511268A1公开(公告)日： 2012-10-17
- 发明人: MASUI, Moriyasu , HORI, AKihiro
- 申请人： Shionogi & Co., Ltd.
- 申请人地址： 1-8 Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-0045 JP
- 专利权人： Shionogi & Co., Ltd.
- 当前专利权人： Shionogi & Co., Ltd.
- 当前专利权人地址： 1-8 Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-0045 JP
- 代理机构： Vossius & Partner
- 优先权： JP2009282184 20091211; JP2010237030 20101022
- 国际公布： WO2011071135 20110616
- 主分类号： C07D265/06
- IPC分类号： C07D265/06 ; A61K31/535 ; A61K31/5355 ; A61K31/5365 ; A61P25/16 ; A61P25/28 ; A61P27/02 ; A61P43/00 ; C07D265/08 ; C07D413/12 ; C07D413/14 ; C07D498/04
摘要：
The present invention provides, for example, a compound mentioned below as a medicament for treating or preventing the diseases induced by production, secretion or deposition of amyloid-β proteins.
A compound of the formula (I):
wherein R 1 , R 2a , R 2b , R 3 , R 4a , R 4b , ring A and the dashed lines are defined in the specification,
its pharmaceutically acceptable salt or a solvate thereof.
A compound of the formula (I):
wherein R 1 , R 2a , R 2b , R 3 , R 4a , R 4b , ring A and the dashed lines are defined in the specification,
its pharmaceutically acceptable salt or a solvate thereof.
公开/授权文献
- EP2511268B2 OXAZINE DERIVATIVE 公开/授权日：2021-02-17
信息查询
